Corrigendum: ESR1 fusions and therapeutic resistance in metastatic breast cancer

Affiliations

Zsuzsanna Nagy: Center for Functional Cancer Epigenetics, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States
Zsuzsanna Nagy: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States
Zsuzsanna Nagy: Department of Medicine, Harvard Medical School, Boston, MA, United States
Rinath Jeselsohn: Center for Functional Cancer Epigenetics, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States
Rinath Jeselsohn: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States
Rinath Jeselsohn: Department of Medicine, Harvard Medical School, Boston, MA, United States
Rinath Jeselsohn: Susan F. Smith Center for Women’s Cancers, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States

Abstract

No abstracts available.

ISSN: 2234-943X (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://www.frontiersin.org/journals/oncology/